Michael P. Lisanti, MD-PhD, FRSA, FRSB, FRSC
Professor and Chair of Translational Medicine, University of Salford (Greater Manchester)
Verified email at salford.ac.uk
Cited by 119962
Vamsi Mootha
Massachusetts General Hospital, Harvard Medical School, HHMI
Verified email at hms.harvard.edu
Cited by 117105
Csaba Szabo
Professor, Chair of Pharmacology, University of Fribourg, Switzerland
Verified email at unifr.ch
Cited by 88136
Rosario Rizzuto
Professor of General Pathology, Dept. Biomedical Sciences, University of Padua, Italy
Verified email at unipd.it
Cited by 85126
Navdeep Chandel
Professor of Medicine, Biochemistry and Molecular Genetics, Northwestern University
Verified email at northwestern.edu
Cited by 83685
Pere Puigserver
Professor of Cell and Cancer Biology, Harvard Medical School
Verified email at dfci.harvard.edu
Cited by 81714
David Eldon Clapham
HHMI, Janelia Research Campus, Ashburn, Virginia, USA
Verified email at janelia.hhmi.org
Cited by 78907
Michael P Murphy
MRC Mitochondrial BIology Unit, University of Cambridge
Verified email at mrc-mbu.cam.ac.uk
Cited by 78502